Riskpilot← Back to searchSign inGet full accessLOVISENBERG LEGESENTER DA
DAActiveOrg 984975503Geitmyrsveien 45B, 0455 OsloGeneral medical practice activities · NACE 8621Est. 20022 employeeswww.mlege.no
Revenue 2022
NOK 3,4M
-23% vs 2021
EBITDA margin
-23.2%
-148% vs 2021
Equity ratio
66.6%
Financial strength
Net profit 2022
NOK -803K
-149% vs 2021
| Revenue | NOK 3,4M | -23% |
| EBITDA | NOK -795K | -148% |
| Net profit | NOK -803K | -149% |
| Total assets | NOK 1,2M | -36% |
| Equity | NOK 787K | -51% |
| Employees | 2 | — |
Legal name
LOVISENBERG LEGESENTER DA
Org number
984975503
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8621 · General medical practice activities
Founded
6. november 2002
Share capital
—
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Utgår
Company purpose
Drift av gruppepraksis i allmennmedisin i lovisenberg legesenter.
Address
Geitmyrsveien 45B, 0455 Oslo
Website
www.mlege.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 2 141 | 4 231 | 3 727 | 4 459 | 3 429 |
| Staff expenses | −1 323 | −1 209 | −1 098 | −925 | −1 072 |
| EBITDA | −846 | 1 133 | 794 | 1 647 | −795 |
| Depreciation & amort. | −0 | −74 | −16 | −0 | −7 |
| EBIT | −846 | 1 058 | 779 | 1 647 | −803 |
| Net financials | 0 | 2 | −1 | 0 | 0 |
| Profit before tax | −846 | 1 061 | 777 | 1 647 | −803 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −846 | 1 061 | 777 | 1 647 | −803 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | −670 | 1 657 | 1 781 | 1 839 | 1 181 |
| Equity | −1 896 | −835 | −57 | 1 590 | 787 |
| Long-term debt | 0 | 0 | 0 | 28 | 0 |
| Short-term debt | 1 225 | 2 492 | 1 839 | 221 | 394 |
| Total debt | 1 225 | 2 492 | 1 839 | 249 | 394 |
EBITDA margin
-23.2%
This company
15.8%
Market median
-247% vs market
20182022
Equity ratio
66.6%
This company
38.2%
Market median
+74% vs market
20182022
Return on equity
-102.0%
This company
18.4%
Market median
-654% vs market
20182022
Net profit margin
-23.4%
This company
8.1%
Market median
-389% vs market
20182022
Asset turnover
2.90×
This company
1.12×
Market median
+159% vs market
20182022
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OB Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
NF Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 0% | 0% | 2018 | |
| Individual | 0% | 0% | 2022 | |
| Individual | 0% | 0% | 2022 | |
| Individual | 0% | 0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LOVISENBERG LEGESENTER DA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Fredrik Holm Moseid | Chief Executive Officer | 0 companies |
| Ole Bendik Kjellstad | Chief Executive Officer | 0 companies |